| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.098 | 0.01 |
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | 0.096 | 0.01 |
| mRNA | BRD-K01737880 | CTRPv2 | pan-cancer | AAC | 0.32 | 0.01 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.094 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.01 |